1. Home
  2. ATRA vs LGL Comparison

ATRA vs LGL Comparison

Compare ATRA & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

N/A

Current Price

$9.00

Market Cap

81.2M

Sector

Health Care

ML Signal

N/A

Logo LGL Group Inc. (The)

LGL

LGL Group Inc. (The)

N/A

Current Price

$7.41

Market Cap

93.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ATRA
LGL
Founded
2012
1917
Country
United States
United States
Employees
N/A
7
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
81.2M
93.0M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
ATRA
LGL
Price
$9.00
$7.41
Analyst Decision
Sell
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
44.7K
10.7K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
122.52
37.50
EPS
N/A
N/A
Revenue
$120,772,000.00
$4,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.92
$5.45
52 Week High
$19.15
$7.88

Technical Indicators

Market Signals
Indicator
ATRA
LGL
Relative Strength Index (RSI) 51.47 51.72
Support Level $9.03 $6.65
Resistance Level $11.17 $7.39
Average True Range (ATR) 0.66 0.22
MACD 0.08 -0.00
Stochastic Oscillator 62.01 34.62

Price Performance

Historical Comparison
ATRA
LGL

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment, and manufacturing business activities. The company has two reportable segments: Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications, including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

Share on Social Networks: